Global Cell Therapy and Tissue Engineering Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Publisher Name :
Date: 22-Jul-2019
No. of pages: 135

Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules.

Scope of the Report:

Cell therapy is the use of living cells to treat or potentially cure a human disease or injury. Tissue Engineering (TE) is a medical field that focuses on restoring, maintaining, improving, or replacing damaged tissues and organs through a combination of scaffolds, cells, and biologically active molecules. Cell therapy, genetically modified cell therapy, gene therapy and tissue engineering are the four pillars of Regenerative Medicine (RM). These therapies have the potential to beneficially alter the quality of life and improve the health of patients with cell defects, genetic diseases, neurodegenerative diseases, tissue malignancies and other medical conditions.

The global Cell Therapy and Tissue Engineering market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell Therapy and Tissue Engineering.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Cell Therapy and Tissue Engineering market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell Therapy and Tissue Engineering market by product type and applications/end industries.

Market Segment by Companies, this report covers

- Betalin Therapeutics

- BioCardia, Inc

- BioReliance Corporation

- Biosolution Co., Ltd.

- Brainstorm Cell Therapeutics, Inc

- MaxCyte, Inc

- Medigene AG

- MEDIPOST CO., Ltd.

- Mesoblast Limited

- Miromatrix Medical, Inc.

- MolMed S.p.A

- Mustang Bio, Inc

- NantKwest, Inc.

- Neuralstem, Inc

- NexImmune, Inc.

- Nohla Therapeutics, Inc

- ReNeuron Group plc

- Richter-Helm BioLogics GmbH & Co. KG

- RoosterBio, Inc

- RoslinCT

- Rubius Therapeutics, Inc.

- Sangamo Therapeutics, Inc

- Voyager Therapeutics, Inc

- Waisman Biomanufacturing

- WindMIL Therapeutics, Inc.

- Wuxi App Tec, Inc.

- ReNeuron Group plc

- Richter-Helm BioLogics GmbH & Co. KG

- RoosterBio, Inc

- RoslinCT

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Cell Therapy

- Tissue Engineering

Market Segment by Applications, can be divided into

- Cell Defects

- Genetic Diseases

- Neurodegenerative Diseases

- Tissue Malignancies

- Others

Global Cell Therapy and Tissue Engineering Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Cell Therapy and Tissue Engineering Market Overview
1.1 Product Overview and Scope of Cell Therapy and Tissue Engineering
1.2 Classification of Cell Therapy and Tissue Engineering by Types
1.2.1 Global Cell Therapy and Tissue Engineering Revenue Comparison by Types (2019-2024)
1.2.2 Global Cell Therapy and Tissue Engineering Revenue Market Share by Types in 2018
1.2.3 Cell Therapy
1.2.4 Tissue Engineering
1.3 Global Cell Therapy and Tissue Engineering Market by Application
1.3.1 Global Cell Therapy and Tissue Engineering Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Cell Defects
1.3.3 Genetic Diseases
1.3.4 Neurodegenerative Diseases
1.3.5 Tissue Malignancies
1.3.6 Others
1.4 Global Cell Therapy and Tissue Engineering Market by Regions
1.4.1 Global Cell Therapy and Tissue Engineering Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cell Therapy and Tissue Engineering Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cell Therapy and Tissue Engineering Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell Therapy and Tissue Engineering Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cell Therapy and Tissue Engineering Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell Therapy and Tissue Engineering Status and Prospect (2014-2024)
1.5 Global Market Size of Cell Therapy and Tissue Engineering (2014-2024)
2 Company Profiles
2.1 Betalin Therapeutics
2.1.1 Business Overview
2.1.2 Cell Therapy and Tissue Engineering Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.2 BioCardia, Inc
2.2.1 Business Overview
2.2.2 Cell Therapy and Tissue Engineering Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.3 BioReliance Corporation
2.3.1 Business Overview
2.3.2 Cell Therapy and Tissue Engineering Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.4 Biosolution Co., Ltd.
2.4.1 Business Overview
2.4.2 Cell Therapy and Tissue Engineering Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biosolution Co., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.5 Brainstorm Cell Therapeutics, Inc
2.5.1 Business Overview
2.5.2 Cell Therapy and Tissue Engineering Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.6 MaxCyte, Inc
2.6.1 Business Overview
2.6.2 Cell Therapy and Tissue Engineering Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.7 Medigene AG
2.7.1 Business Overview
2.7.2 Cell Therapy and Tissue Engineering Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Medigene AG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.8 MEDIPOST CO., Ltd.
2.8.1 Business Overview
2.8.2 Cell Therapy and Tissue Engineering Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 MEDIPOST CO., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.9 Mesoblast Limited
2.9.1 Business Overview
2.9.2 Cell Therapy and Tissue Engineering Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.10 Miromatrix Medical, Inc.
2.10.1 Business Overview
2.10.2 Cell Therapy and Tissue Engineering Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.11 MolMed S.p.A
2.11.1 Business Overview
2.11.2 Cell Therapy and Tissue Engineering Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.12 Mustang Bio, Inc
2.12.1 Business Overview
2.12.2 Cell Therapy and Tissue Engineering Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.13 NantKwest, Inc.
2.13.1 Business Overview
2.13.2 Cell Therapy and Tissue Engineering Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.14 Neuralstem, Inc
2.14.1 Business Overview
2.14.2 Cell Therapy and Tissue Engineering Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.15 NexImmune, Inc.
2.15.1 Business Overview
2.15.2 Cell Therapy and Tissue Engineering Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.16 Nohla Therapeutics, Inc
2.16.1 Business Overview
2.16.2 Cell Therapy and Tissue Engineering Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.17 ReNeuron Group plc
2.17.1 Business Overview
2.17.2 Cell Therapy and Tissue Engineering Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.18 Richter-Helm BioLogics GmbH & Co. KG
2.18.1 Business Overview
2.18.2 Cell Therapy and Tissue Engineering Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.19 RoosterBio, Inc
2.19.1 Business Overview
2.19.2 Cell Therapy and Tissue Engineering Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.20 RoslinCT
2.20.1 Business Overview
2.20.2 Cell Therapy and Tissue Engineering Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.21 Rubius Therapeutics, Inc.
2.21.1 Business Overview
2.21.2 Cell Therapy and Tissue Engineering Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.22 Sangamo Therapeutics, Inc
2.22.1 Business Overview
2.22.2 Cell Therapy and Tissue Engineering Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.23 Voyager Therapeutics, Inc
2.23.1 Business Overview
2.23.2 Cell Therapy and Tissue Engineering Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.24 Waisman Biomanufacturing
2.24.1 Business Overview
2.24.2 Cell Therapy and Tissue Engineering Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.25 WindMIL Therapeutics, Inc.
2.25.1 Business Overview
2.25.2 Cell Therapy and Tissue Engineering Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.26 Wuxi App Tec, Inc.
2.26.1 Business Overview
2.26.2 Cell Therapy and Tissue Engineering Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.27 ReNeuron Group plc
2.27.1 Business Overview
2.27.2 Cell Therapy and Tissue Engineering Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.28 Richter-Helm BioLogics GmbH & Co. KG
2.28.1 Business Overview
2.28.2 Cell Therapy and Tissue Engineering Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.29 RoosterBio, Inc
2.29.1 Business Overview
2.29.2 Cell Therapy and Tissue Engineering Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
2.30 RoslinCT
2.30.1 Business Overview
2.30.2 Cell Therapy and Tissue Engineering Type and Applications
2.30.2.1 Product A
2.30.2.2 Product B
2.30.3 RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cell Therapy and Tissue Engineering Market Competition, by Players
3.1 Global Cell Therapy and Tissue Engineering Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell Therapy and Tissue Engineering Players Market Share
3.2.2 Top 10 Cell Therapy and Tissue Engineering Players Market Share
3.3 Market Competition Trend
4 Global Cell Therapy and Tissue Engineering Market Size by Regions
4.1 Global Cell Therapy and Tissue Engineering Revenue and Market Share by Regions
4.2 North America Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
4.3 Europe Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
4.5 South America Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
5 North America Cell Therapy and Tissue Engineering Revenue by Countries
5.1 North America Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
5.2 USA Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
5.3 Canada Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
5.4 Mexico Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
6 Europe Cell Therapy and Tissue Engineering Revenue by Countries
6.1 Europe Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
6.2 Germany Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
6.3 UK Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
6.4 France Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
6.5 Russia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
6.6 Italy Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cell Therapy and Tissue Engineering Revenue by Countries
7.1 Asia-Pacific Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
7.2 China Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
7.3 Japan Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
7.4 Korea Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
7.5 India Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
8 South America Cell Therapy and Tissue Engineering Revenue by Countries
8.1 South America Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
8.2 Brazil Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
8.3 Argentina Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
8.4 Colombia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cell Therapy and Tissue Engineering by Countries
9.1 Middle East and Africa Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
9.3 UAE Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
9.4 Egypt Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
9.6 South Africa Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
10 Global Cell Therapy and Tissue Engineering Market Segment by Type
10.1 Global Cell Therapy and Tissue Engineering Revenue and Market Share by Type (2014-2019)
10.2 Global Cell Therapy and Tissue Engineering Market Forecast by Type (2019-2024)
10.3 Cell Therapy Revenue Growth Rate (2014-2024)
10.4 Tissue Engineering Revenue Growth Rate (2014-2024)
11 Global Cell Therapy and Tissue Engineering Market Segment by Application
11.1 Global Cell Therapy and Tissue Engineering Revenue Market Share by Application (2014-2019)
11.2 Cell Therapy and Tissue Engineering Market Forecast by Application (2019-2024)
11.3 Cell Defects Revenue Growth (2014-2019)
11.4 Genetic Diseases Revenue Growth (2014-2019)
11.5 Neurodegenerative Diseases Revenue Growth (2014-2019)
11.6 Tissue Malignancies Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Cell Therapy and Tissue Engineering Market Size Forecast (2019-2024)
12.1 Global Cell Therapy and Tissue Engineering Market Size Forecast (2019-2024)
12.2 Global Cell Therapy and Tissue Engineering Market Forecast by Regions (2019-2024)
12.3 North America Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
12.4 Europe Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
12.6 South America Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cell Therapy and Tissue Engineering Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Cell Therapy and Tissue Engineering Picture
Table Product Specifications of Cell Therapy and Tissue Engineering
Table Global Cell Therapy and Tissue Engineering and Revenue (Million USD) Market Split by Product Type
Figure Global Cell Therapy and Tissue Engineering Revenue Market Share by Types in 2018
Figure Cell Therapy Picture
Figure Tissue Engineering Picture
Table Global Cell Therapy and Tissue Engineering Revenue (Million USD) by Application (2014-2024)
Figure Cell Therapy and Tissue Engineering Revenue Market Share by Applications in 2018
Figure Cell Defects Picture
Figure Genetic Diseases Picture
Figure Neurodegenerative Diseases Picture
Figure Tissue Malignancies Picture
Figure Others Picture
Table Global Market Cell Therapy and Tissue Engineering Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (2014-2024)
Table Betalin Therapeutics Basic Information, Manufacturing Base and Competitors
Table Betalin Therapeutics Cell Therapy and Tissue Engineering Type and Applications
Table Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table BioCardia, Inc Basic Information, Manufacturing Base and Competitors
Table BioCardia, Inc Cell Therapy and Tissue Engineering Type and Applications
Table BioCardia, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table BioReliance Corporation Basic Information, Manufacturing Base and Competitors
Table BioReliance Corporation Cell Therapy and Tissue Engineering Type and Applications
Table BioReliance Corporation Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Biosolution Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table Biosolution Co., Ltd. Cell Therapy and Tissue Engineering Type and Applications
Table Biosolution Co., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Brainstorm Cell Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table MaxCyte, Inc Basic Information, Manufacturing Base and Competitors
Table MaxCyte, Inc Cell Therapy and Tissue Engineering Type and Applications
Table MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Medigene AG Basic Information, Manufacturing Base and Competitors
Table Medigene AG Cell Therapy and Tissue Engineering Type and Applications
Table Medigene AG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table MEDIPOST CO., Ltd. Basic Information, Manufacturing Base and Competitors
Table MEDIPOST CO., Ltd. Cell Therapy and Tissue Engineering Type and Applications
Table MEDIPOST CO., Ltd. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Mesoblast Limited Basic Information, Manufacturing Base and Competitors
Table Mesoblast Limited Cell Therapy and Tissue Engineering Type and Applications
Table Mesoblast Limited Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Miromatrix Medical, Inc. Basic Information, Manufacturing Base and Competitors
Table Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table MolMed S.p.A Basic Information, Manufacturing Base and Competitors
Table MolMed S.p.A Cell Therapy and Tissue Engineering Type and Applications
Table MolMed S.p.A Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Mustang Bio, Inc Basic Information, Manufacturing Base and Competitors
Table Mustang Bio, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table NantKwest, Inc. Basic Information, Manufacturing Base and Competitors
Table NantKwest, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Neuralstem, Inc Basic Information, Manufacturing Base and Competitors
Table Neuralstem, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table NexImmune, Inc. Basic Information, Manufacturing Base and Competitors
Table NexImmune, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Nohla Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table ReNeuron Group plc Basic Information, Manufacturing Base and Competitors
Table ReNeuron Group plc Cell Therapy and Tissue Engineering Type and Applications
Table ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Richter-Helm BioLogics GmbH & Co. KG Basic Information, Manufacturing Base and Competitors
Table Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Type and Applications
Table Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table RoosterBio, Inc Basic Information, Manufacturing Base and Competitors
Table RoosterBio, Inc Cell Therapy and Tissue Engineering Type and Applications
Table RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table RoslinCT Basic Information, Manufacturing Base and Competitors
Table RoslinCT Cell Therapy and Tissue Engineering Type and Applications
Table RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Rubius Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Sangamo Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Voyager Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Type and Applications
Table Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Waisman Biomanufacturing Basic Information, Manufacturing Base and Competitors
Table Waisman Biomanufacturing Cell Therapy and Tissue Engineering Type and Applications
Table Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table WindMIL Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Wuxi App Tec, Inc. Basic Information, Manufacturing Base and Competitors
Table Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Type and Applications
Table Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table ReNeuron Group plc Basic Information, Manufacturing Base and Competitors
Table ReNeuron Group plc Cell Therapy and Tissue Engineering Type and Applications
Table ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Richter-Helm BioLogics GmbH & Co. KG Basic Information, Manufacturing Base and Competitors
Table Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Type and Applications
Table Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table RoosterBio, Inc Basic Information, Manufacturing Base and Competitors
Table RoosterBio, Inc Cell Therapy and Tissue Engineering Type and Applications
Table RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table RoslinCT Basic Information, Manufacturing Base and Competitors
Table RoslinCT Cell Therapy and Tissue Engineering Type and Applications
Table RoslinCT Cell Therapy and Tissue Engineering Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cell Therapy and Tissue Engineering Revenue (Million USD) by Players (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue Share by Players (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Share by Players in 2017
Figure Global Cell Therapy and Tissue Engineering Revenue Share by Players in 2018
Figure Global Top 5 Players Cell Therapy and Tissue Engineering Revenue Market Share in 2018
Figure Global Top 10 Players Cell Therapy and Tissue Engineering Revenue Market Share in 2018
Figure Global Cell Therapy and Tissue Engineering Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue (Million USD) by Regions (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue Market Share by Regions (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Market Share by Regions (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Market Share by Regions in 2018
Figure North America Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Europe Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure South America Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table North America Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
Table North America Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure North America Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure North America Cell Therapy and Tissue Engineering Revenue Market Share by Countries in 2018
Figure USA Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Canada Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Mexico Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table Europe Cell Therapy and Tissue Engineering Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure Europe Cell Therapy and Tissue Engineering Revenue Market Share by Countries in 2018
Figure Germany Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure UK Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure France Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Russia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Italy Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cell Therapy and Tissue Engineering Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cell Therapy and Tissue Engineering Revenue Market Share by Countries in 2018
Figure China Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Japan Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Korea Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure India Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table South America Cell Therapy and Tissue Engineering Revenue by Countries (2014-2019)
Table South America Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure South America Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure South America Cell Therapy and Tissue Engineering Revenue Market Share by Countries in 2018
Figure Brazil Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Argentina Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Colombia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cell Therapy and Tissue Engineering Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cell Therapy and Tissue Engineering Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cell Therapy and Tissue Engineering Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure UAE Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Egypt Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure Nigeria Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Figure South Africa Cell Therapy and Tissue Engineering Revenue and Growth Rate (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue (Million USD) by Type (2014-2019)
Table Global Cell Therapy and Tissue Engineering Revenue Share by Type (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Share by Type (2014-2019)
Figure Global Cell Therapy and Tissue Engineering Revenue Share by Type in 2018
Table Global Cell Therapy and Tissue Engineering Revenue Forecast by Type (2019-2024)
Figure Global Cell Therapy and Tissue Engineering Market Share Forecast by Type (2019-2024)
Figure Global Cell Therapy Revenue Growth Rate (2014-2019)
Figure Global Tissue Engineering Revenue Growth Rate (2014-2019)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs